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Resumo
Bilirubin (BL) is a bile pigment that arises from the catabolism of hemeproteins and it is an important 
biochemical marker for diagnosis and monitoring of hepatic and hematologic diseases. The high 
concentration of this metabolite in plasma may be associated with disturbances in production, metabolism 
and/or excretion. Several in vivo in vitro studies have established the antioxidant, anti-inflammatory and 
anti-tumoral bilirubin capacity. The main objective was to verify that the effects of certain drugs and 
nutritional compounds on the metabolism of bilirubin, as well as studying the effects of radical substances 
in the UGT1A1 gene in addition have also studied the effect of various enzymes on serum bilirubin. The 
methodology was a detailed search online database, such as Pubmed, NCBI, ScienceDirect and books, 
a five-month period. Several studies refer four botanical groups as associated to changes in bilirubin 
concentrations Cruciferae (e.g., broccoli), Rutaceae (citrus), Liliaceae (e.g., onions), and Leguminosae 
(legumes). In a hyperbilirubinemic condition, the best approach would include the increasing UGT1A1 
expression and this can be achieved with foods from the botanical families Cruciferae, Rutaceae, Liliaceae, 
and Leguminosae. Regulation of UGTs by phytochemicals has been investigated with a focus on cancer 
prevention numerous inhibitors from plant origin. The strategy to rise SBL, inhibiting UGT1A1 activity 
appears unreasonable. Several studies show that low serum bilirubin concentrations are associated with 
an increased risk of chronic diseases, whereas slightly elevated serum bilirubin levels seems to provide 
protection. The enzymes HO-1 and BLV will also have an important role in the development of therapeutic 
strategies based on dietary compounds however for these two enzymes there was considerable less 
information about their inducers and inhibitors. It is proven that the ingestion of certain foods affects the 
metabolism of bilirubin and the expression of UGT1A1 gene. Thus, it is justified the need for further studies 
to demonstrate the potential of food to control the maintenance of bilirubin in order to identify possible 
functional foods. 
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